Absorption, Distribution, Metabolism And Excretion Study For GSK221149A

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

This is a phase one study investigating the absorption, distribution, metabolism and excretion of GSK221149A in six healthy women of non-child bearing potential.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion criteria:

• Healthy adult, non-smoking females

• Aged between 30 - 55 years old, and BMI of between 19 and 32

• Not of child-bearing potential

Exclusion criteria:

• No clinically significant findings on clinical examination, medical examination and blood tests.

• Radiation exposure over previous 3 years is greater than 10mSv

• History of bleeding or gastric problems